Buddate Reges Intensive Treatment Cream
NDC Package 71173-3000-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Buddate Reges Intensive Treatment (butylene glycol, hydrogenated coconut oil, butyrospermum parkii (shea) butter, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7) cream is apply a generous amount of the cream three times a day to your body needing to be nourishd, and then softly massage your skin. This formulation utilizes a cream delivery system. Marketed by Buddate Co Ltd, this product is identified by NDC 71173-3000.

Identification & Billing

NDC Package Code
71173-3000-1
Package Description
70 mL in 1 TUBE
Product Code
71173-3000
11-Digit Billing Format
71173300001

Clinical Specifications

Proprietary Name
Buddate Reges Intensive Treatment
Non-Proprietary Name
Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
Substance Name
Butylene Glycol; Hydrogenated Coconut Oil; Palmitoyl Tetrapeptide-7; Palmitoyl Tripeptide-1; Shea Butter
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Apply a generous amount of the cream three times a day to your body needing to be nourishd, and then softly massage your skin.

Regulatory & Marketing

Labeler Name
Buddate Co Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71173-3000-1 identifies a specific commercial package of 70 ml in 1 tube of Buddate Reges Intensive Treatment, a human over the counter drug labeled by Buddate Co Ltd. This cream is formulated for topical use and contains butylene glycol; hydrogenated coconut oil; palmitoyl tetrapeptide-7; palmitoyl tripeptide-1; shea butter as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Buddate Co Ltd on January 01, 2017. The current certification is valid through December 31, 2026.

How is this Buddate Co Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71173300001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71173-3000-1
11-Digit CMS (5-4-2)
71173-3000-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.